Schering Corporation (JOBS), Merck & Co., Inc. (JOBS) Spent $60 Million on Medical Education For Doctors

Published: Sep 15, 2009

Bookmark and Share

Dow Jones -- Merck & Co. and Schering-Plough Corp., makers of the controversial cholesterol drug Vytorin, spent roughly $60 million over four years on classes to help doctors learn the latest practices and treatment options for heart disease.

Back to news